BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12647807)

  • 1. Dynamics of lineage-restricted mixed chimerism following sex-mismatched allogeneic bone marrow transplantation.
    Thiele J; Wickenhauser C; Kvasnicka HM; Varus E; Beelen DW; Schaefer UW
    Histol Histopathol; 2003 Apr; 18(2):557-74. PubMed ID: 12647807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed chimerism of erythro- and megakaryopoiesis following allogeneic bone marrow transplantation.
    Thiele J; Wickenhauser C; Kvasnicka HM; Varus E; Schneider C; Müller H; Beelen DW
    Acta Haematol; 2003; 109(4):176-83. PubMed ID: 12853689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed chimerism of bone marrow CD34+ progenitor cells (genotyping, bcr/abl analysis) after allogeneic transplantation for chronic myelogenous leukemia.
    Thiele J; Wickenhauser C; Kvasnicka HM; Varus E; Kleppe S; Beelen DW; Schaefer UW
    Transplantation; 2002 Oct; 74(7):982-6. PubMed ID: 12394842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed chimerism of the resident macrophage population after allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Wickenhauser C; Thiele J; Pérez F; Varus E; Stoffel MS; Kvasnicka HM; Beelen DW; Schaefer UW
    Transplantation; 2002 Jan; 73(1):104-11. PubMed ID: 11792988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed chimerism of bone marrow vessels (endothelial cells, myofibroblasts) following allogeneic transplantation for chronic myelogenous leukemia.
    Kvasnicka HM; Wickenhauser C; Thiele J; Varus E; Hamm K; Beelen DW; Schaefer UW
    Leuk Lymphoma; 2003 Feb; 44(2):321-8. PubMed ID: 12688352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells.
    Kögler G; Wolf HH; Heyll A; Arkesteijn G; Wernet P
    Bone Marrow Transplant; 1995 Jan; 15(1):41-8. PubMed ID: 7742754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
    Suttorp M; Schmitz N; Dreger P; Schaub J; Löffler H
    Leukemia; 1993 May; 7(5):679-87. PubMed ID: 8097800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantation.
    Thiele J; Varus E; Siebolts U; Kvasnicka HM; Wickenhauser C; Metz KA; Beelen DW; Ditschkowski M; Zander A; Kröger N
    Histol Histopathol; 2007 Apr; 22(4):365-72. PubMed ID: 17290346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
    Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
    Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
    Román J; Alvarez MA; Torres A
    Haematologica; 2000 Oct; 85(10):1072-82. PubMed ID: 11025600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation.
    Hessel H; Mittermüller J; Zitzelsberger H; Weier HU; Bauchinger M
    Histochem Cell Biol; 1996 Nov; 106(5):481-5. PubMed ID: 8950606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of CD34+ progenitor cells following allogeneic bone marrow transplantation in Ph1+CML--an immunohistochemical study on 113 patients with sequential trephine biopsies.
    Thiele J; Kvasnicka HM; Beelen DW; Cicek G; Leder LD; Schaefer UW
    J Hematother Stem Cell Res; 2002 Jun; 11(3):565-74. PubMed ID: 12183841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF.
    Siebolts U; Thiele J; Zander T; Ditschkowski M; Beelen DW; Kröger N; Fehse B; Wickenhauser C
    Oncol Rep; 2008 Jan; 19(1):287-92. PubMed ID: 18097609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.
    Bär BM; Schattenberg A; Mensink EJ; Geurts Van Kessel A; Smetsers TF; Knops GH; Linders EH; De Witte T
    J Clin Oncol; 1993 Mar; 11(3):513-9. PubMed ID: 8445426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients.
    Thiele J; Kvasnicka HM; Beelen DW; Leder LD; Schaefer UW
    Histol Histopathol; 2001 Jan; 16(1):213-26. PubMed ID: 11193198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
    Elmaagacli AH; Becks HW; Beelen DW; Stockova J; Bützler R; Opalka B; Schaefer UW
    Bone Marrow Transplant; 1995 Dec; 16(6):823-9. PubMed ID: 8750276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex chromosome changes after sex-mismatched allogeneic bone marrow transplantation can mislead the chimerism analysis.
    Alpár D; Nagy G; Hohoff C; Kajtár B; Bartyik K; Hermesz J; Jáksó P; Andrikovics H; Kereskai L; Pajor L
    Pediatr Blood Cancer; 2010 Dec; 55(6):1239-42. PubMed ID: 20979181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.